Yang Feng Selected Research

PHiD-CV vaccine

12/2022

Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yang Feng Research Topics

Disease

65	Neoplasms (Cancer) 08/2022 - 01/2006
15	Infections 03/2022 - 01/2006
11	Inflammation (Inflammations) 01/2021 - 01/2009
8	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2006
8	Colorectal Neoplasms (Colorectal Cancer) 03/2021 - 06/2015
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 08/2009
6	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2009
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2010
6	Lymphoma (Lymphomas) 09/2019 - 06/2009
6	Human Influenza (Influenza) 10/2017 - 06/2013
5	Colonic Neoplasms (Colon Cancer) 11/2022 - 06/2015
5	Carcinoma (Carcinomatosis) 04/2022 - 12/2008
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 05/2015
5	Leukemia 01/2022 - 01/2018
5	Lymphatic Metastasis 01/2022 - 10/2011
4	Ovarian Neoplasms (Ovarian Cancer) 08/2022 - 05/2016
4	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 01/2010
3	Ulcerative Colitis 04/2022 - 01/2019
3	Sepsis (Septicemia) 01/2022 - 01/2018
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2018
3	Fibrosis (Cirrhosis) 01/2019 - 01/2018
3	Rectal Neoplasms (Rectal Cancer) 01/2019 - 04/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 03/2014 - 04/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2013 - 09/2007
2	Otitis Media 12/2022 - 01/2021
2	Persistent Infection 03/2022 - 10/2009
2	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2019
2	Lung Injury 01/2022 - 10/2019
2	Adenocarcinoma 10/2021 - 11/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2019
2	Insulin Resistance 01/2021 - 07/2017
2	Severe Fever with Thrombocytopenia Syndrome 01/2021 - 01/2020
2	Brain Diseases (Brain Disorder) 01/2020 - 06/2015
2	Nervous System Diseases (Neurological Disorders) 01/2020 - 03/2016
2	Poisoning 04/2019 - 01/2018
2	Rheumatoid Arthritis 01/2019 - 04/2011

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 08/2022 - 10/2011
11	Monoclonal AntibodiesIBA 01/2022 - 03/2008
8	Pharmaceutical PreparationsIBA 08/2022 - 04/2010
8	AntibodiesIBA 12/2021 - 01/2006
7	Immunoglobulin G (IgG)IBA 01/2022 - 01/2006
7	LigandsIBA 01/2022 - 01/2006
6	VaccinesIBA 12/2022 - 01/2012
6	AntigensIBA 09/2019 - 10/2008
5	Chimeric Antigen ReceptorsIBA 01/2021 - 05/2015
5	Messenger RNA (mRNA)IBA 01/2019 - 01/2018
5	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2017 - 06/2013
5	Insulin-Like PeptidesIBA 12/2014 - 01/2006
5	Insulin-Like Growth Factor II (Somatomedin A)IBA 11/2012 - 01/2006
4	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 06/2016
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2010
4	Indicators and Reagents (Reagents)IBA 03/2021 - 06/2015
4	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 10/2017
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 08/2009
4	Bevacizumab (Avastin)FDA Link 01/2018 - 04/2013
4	Rituximab (Mabthera)FDA Link 03/2014 - 06/2009
3	Peptides (Polypeptides)IBA 08/2022 - 09/2013
3	Particulate MatterIBA 08/2022 - 06/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2004
3	NucleosidesIBA 01/2022 - 09/2013
3	Long Noncoding RNAIBA 11/2021 - 10/2018
3	Phosphotransferases (Kinase)IBA 08/2021 - 07/2004
3	Therapeutic UsesIBA 01/2021 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 05/2019 - 06/2015
3	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 04/2013
3	Leucovorin (Folinic Acid)FDA Link 01/2018 - 04/2013
3	Gemcitabine FDA Link 01/2018 - 08/2009
3	Folic Acid (Vitamin M)FDA LinkGeneric 06/2015 - 04/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2014 - 05/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2014 - 05/2010
3	Insulin-Like Growth Factor I (IGF-1)IBA 11/2012 - 01/2006
3	Glycoproteins (Glycoprotein)IBA 10/2009 - 01/2008
2	Conjugate VaccinesIBA 12/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2021
2	Amino Acids FDA Link 11/2022 - 01/2020
2	Capsules (Microcapsules)IBA 04/2022 - 01/2020
2	Dextran SulfateIBA 04/2022 - 01/2020
2	Butyric Acid (Butanoic Acid)IBA 04/2022 - 01/2021
2	Liposomes (Liposome)IBA 01/2022 - 04/2010
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 01/2022
2	Sulfur DioxideIBA 06/2021 - 01/2020
2	Circular RNAIBA 01/2021 - 10/2019
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 02/2020 - 11/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 12/2019
2	CateninsIBA 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 12/2019 - 01/2018
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019 - 02/2018
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2018
2	Bortezomib (Velcade)FDA Link 01/2019 - 10/2014

Therapy/Procedure

32	Therapeutics 01/2022 - 12/2006
11	Radiotherapy 01/2022 - 12/2008
7	Drug Therapy (Chemotherapy) 08/2022 - 01/2010
2	Ligation 01/2022 - 01/2018
2	Punctures 01/2022 - 01/2018
2	Precision Medicine 01/2020 - 12/2019
2	Adjuvant Chemotherapy 01/2019 - 01/2019